Global Clot Management Devices Market Size, Trends and Growth Opportunity, By Product Type, By End-Use, By Region and Forecast to 2027

Global Clot Management Devices Market Size, Trends and Growth Opportunity, By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices, and Inferior vena cava filters (IVCF), Percutaneous Thrombectomy Devices), By End-Use (Hospitals, Diagnostic Centers, Others).

Global Clot Management Devices Market

Global Clot Management Devices Market was valued at USD 1.6 billion in 2021 and would rocket up to USD 2.2 billion by 2027 at a CAGR of 4.39% from 2022-2027.

A clot of blood develops at the end of the hemostasis process. Clots are also referred to as "thrombus." Red blood cells and clumped platelets make up a blood clot, and they work together to produce a plug and a mesh of cross-linked fibrin protein. Blood flow to the heart, brain, lungs, and legs is blocked by clots. Blood clots can cause serious issues in the body, involving blood vessel damage, hypertension, stroke, and occasionally even death. Thrombosis is a substantial contributor to the death of cancer patients. Blood clots can be treated surgically or with anticoagulation drugs.

Market Drivers

The construction of cutting-edge next-generation thrombectomy tools and the speedy advancement of technology will promote the market introduction of clot management devices. As self-monitoring devices received rapid administrative approvals, the market share for clot supervision will also increase. One element in the expansion is the growing senior population, which is more prone to contracting such infections. The potential to minimize hospital investments and waiting times for low-risk lump extraction techniques is expected to expand throughout the projection period as a result of the increased demand for such procedures. Worldwide, 17.9 million people die from cardiovascular disorders each year, according to the World Health Organization (WHO). In addition, a rising demand for minimally invasive treatments for blood clots is predicted to boost market expansion due to the rising occurrence of heart attacks and stroke.

The market will increase in the next years as a result of increasing thrombectomy/embolectomy device demand and growing awareness of cutting-edge clot management procedures. Another significant element is the greater consciousness among patients and medical professionals of the benefits of percutaneous thrombectomy devices over the traditional technique of eliminating clots through open surgery.

Market Restraints

The lack of pay systems and consciousness of preventative medical checks to detect blood clotting, on the other hand, will impede the market's growth rate. The market for clot management devices will face challenges due to a shortage of highly qualified workers and a lack of healthcare infrastructure in emerging nations. Over the projected period, the expansion of the global market for clot management devices is anticipated to be constrained by the high cost of these devices. Many developing nations lack clearly defined reimbursement regulations, which can also impede the expansion of the market for clot management devices globally.

Market Segmentation

Global Clot Management Devices Market is segmented into Product and End-User. By Product Type such as Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices, and Inferior vena cava filters (IVCF), Percutaneous Thrombectomy Devices. By End-Use such as Hospitals, Diagnostic Centers, Others.

Regional Analysis

Global Clot Management Devices Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Due to the rising geriatric population as well as the adoption of cutting-edge medical technology, North America owns and controls the majority of the global market for clot management devices. Because of modifications in lifestyle and improved disposable income, rising prevalence of target diseases along with improved healthcare infrastructure, and the launch of technologically advanced goods, Asia-Pacific is predicted to grow at the greatest rate throughout the forecast period.

Key Players

This report includes a list of numerous Key Players, namely Angio Dynamics, Inc. (U.S.), Applied Medical Resources Corporation (U.S.), Bayer AG (Germany), Boston Scientific Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), EKOS Corporation (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Medtronic (Ireland), Stryker (U.S.), Volcano Corporation (U.S.).

Market Taxonomy

By Product Type

• Percutaneous Thrombectomy Devices
• Mechanical Thrombectomy
• Aspiration Thrombectomy
• Percutaneous Mechanical Thrombectomy (PMT)
• Embolectomy Balloon Catheters
• Catheter-Directed Thrombolysis (CDT) Devices
• Inferior Vena Cava Filters (IVCFS)
• Permanent
• Retrievable
• Neurovascular Embolectomy Devices

By End User

• Hospitals
• Diagnostic Centers
• Others

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa.